Literature DB >> 22229532

Outcomes in community-acquired Clostridium difficile infection.

S Khanna1, D S Pardi, S L Aronson, P P Kammer, L M Baddour.   

Abstract

BACKGROUND: Community-acquired Clostridium difficile infection (CA-CDI) is an increasingly appreciated condition. It is being described in populations lacking traditional predisposing factors that have been previously considered at low-risk for this infection. As most studies of CDI are hospital-based, outcomes in these patients are not well known. AIM: To examine outcomes and their predictors in patients with CA-CDI.
METHODS: A sub-group analysis of a population-based epidemiological study of CDI in Olmsted county, Minnesota from 1991-2005 was performed. Data regarding outcomes, including severity, treatment response, need for hospitalisation and recurrence were analysed.
RESULTS: Of 157 CA-CDI cases, the median age was 50 years and 75.3% were female. Among all CA-CDI cases, 40% required hospitalisation, 20% had severe and 4.4% had severe-complicated infection, 20% had treatment failure and 28% had recurrent CDI. Patients who required hospitalisation were significantly older (64 years vs. 44 years, P < 0.001), more likely to have severe disease (33.3% vs. 11.7%, P = 0.001), and had higher mean Charlson comorbidity index scores (2.06 vs. 0.84, P = 0.001). They had similar treatment failure and recurrence rates as patients who did not require hospitalisation.
CONCLUSIONS: Community-acquired Clostridium difficile infection can be associated with complications and poor outcomes, including hospitalisation and severe Clostridium difficile infection. As the incidence of community-acquired Clostridium difficile infection increases, clinicians should be aware of risk factors (increasing age, comorbid conditions and disease severity) that predict the need for hospitalisation and complications in patients with community-acquired Clostridium difficile infection.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22229532      PMCID: PMC3293482          DOI: 10.1111/j.1365-2036.2011.04984.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  29 in total

1.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

2.  The epidemiology of community-acquired Clostridium difficile infection: a population-based study.

Authors:  Sahil Khanna; Darrell S Pardi; Scott L Aronson; Patricia P Kammer; Robert Orenstein; Jennifer L St Sauver; W Scott Harmsen; Alan R Zinsmeister
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

3.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

4.  Recommendations for surveillance of Clostridium difficile-associated disease.

Authors:  L Clifford McDonald; Bruno Coignard; Erik Dubberke; Xiaoyan Song; Teresa Horan; Preeta K Kutty
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-25       Impact factor: 3.254

5.  Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-12-02       Impact factor: 17.586

6.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

Authors:  Lorraine Kyne; Mary Beth Hamel; Rajashekhar Polavaram; Ciarán P Kelly
Journal:  Clin Infect Dis       Date:  2001-12-17       Impact factor: 9.079

7.  Surveillance for community-associated Clostridium difficile--Connecticut, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-04-04       Impact factor: 17.586

8.  Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization.

Authors:  Eijiro Ozaki; Haru Kato; Hiroyuki Kita; Tadahiro Karasawa; Tsuneo Maegawa; Youko Koino; Kazumasa Matsumoto; Toshihiko Takada; Koji Nomoto; Ryuichiro Tanaka; Shinichi Nakamura
Journal:  J Med Microbiol       Date:  2004-02       Impact factor: 2.472

Review 9.  Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.

Authors:  M P Bauer; A Goorhuis; T Koster; S C Numan-Ruberg; E C Hagen; S B Debast; E J Kuijper; J T van Dissel
Journal:  Neth J Med       Date:  2008-05       Impact factor: 1.422

10.  Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

Authors:  Rocco Ricciardi; David A Rothenberger; Robert D Madoff; Nancy N Baxter
Journal:  Arch Surg       Date:  2007-07
View more
  33 in total

1.  Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection.

Authors:  Sahil Khanna; Arjun Gupta; Larry M Baddour; Darrell S Pardi
Journal:  Intern Emerg Med       Date:  2015-12-22       Impact factor: 3.397

Review 2.  Recurrent Clostridium difficile infection and the microbiome.

Authors:  Rowena Almeida; Teklu Gerbaba; Elaine O Petrof
Journal:  J Gastroenterol       Date:  2015-07-08       Impact factor: 7.527

Review 3.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

4.  Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiaries.

Authors:  Courtney E Collins; M Didem Ayturk; Julie M Flahive; Timothy A Emhoff; Frederick A Anderson; Heena P Santry
Journal:  J Am Coll Surg       Date:  2014-02-28       Impact factor: 6.113

5. 

Authors:  George Kim; Nemin Adam Zhu
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

6.  Community-acquired Clostridium difficile infection.

Authors:  George Kim; Nemin Adam Zhu
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

Review 7.  Clostridium difficile infection: new insights into management.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

Review 8.  Clostridium difficile infection: management strategies for a difficult disease.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Therap Adv Gastroenterol       Date:  2014-03       Impact factor: 4.409

Review 9.  Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.

Authors:  Kathleen Mullane
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

10.  Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children.

Authors:  Julia Shaklee Sammons; Russell Localio; Rui Xiao; Susan E Coffin; Theoklis Zaoutis
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.